An interventional study of Knowledge of Preoperative Urine Culture Results and Blinding to Preoperative Urine Culture Results in Prostatic Hyperplasia, Benign, Urinary Infection and Bacteriuria Asymptomatic, sponsored by Universidad de Antioquia. Not yet recruiting at 1 site in Colombia. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Universidad de Antioquia · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Benign prostatic hyperplasia (BPH) is a common condition in men, and a proportion of affected patients require surgical treatment. Transurethral resection of the prostate (TURP) is considered the gold standard for the surgical management of these patients. Preoperative asymptomatic bacteriuria (ASB) is present in approximately 30% of patients with BPH undergoing TURP. Current guidelines recommend screening for and treating ASB before endoscopic urological procedures associated with mucosal trauma to prevent postoperative infectious complications. However, the precise role of ASB in the development of postoperative urinary tract infections (UTIs) remains unclear, and the quality of the evidence supporting these recommendations is low.
A prospective, comparative clinical study is therefore warranted to determine the effectiveness of preoperative screening for and treatment of ASB in preventing infectious complications in patients with BPH undergoing TURP. The findings may help address existing knowledge gaps, inform future recommendations, and promote adherence to evidence-based clinical decision-making.
The objective of this study is to determine the effectiveness of preoperative screening for and treatment of ASB in preventing postoperative infectious complications in patients with BPH undergoing TURP.
A multicenter, parallel-group, randomized non-inferiority diagnostic test trial is proposed. A total of 1,262 men aged over 45 years with a diagnosis of BPH, an indication for TURP due to BPH, and no signs or symptoms of UTI will be enrolled. Participants will be randomly assigned in a 1:1 ratio to one of two groups according to whether the results of the preoperative urine culture are disclosed or withheld. Participants will be followed up for one month, and the primary outcome will be the occurrence of urinary tract infection (UTI).
The study was approved for review by the Research Ethics Committee of the Faculty of Medicine at the University of Antioquia and by the ethics committees of all participating institutions involved in patient recruitment.
828 studies on the registry are indexed under Prostatic Hyperplasia; 179 are open to participants now.
This study's planned enrollment of 1,262 is above the median of 92 across 627 interventional studies indexed under Prostatic Hyperplasia.
Browse Prostatic Hyperplasia studies →Universidad de Antioquia is the lead sponsor of 80 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Disclosure of preoperative urine culture results
Other: Knowledge of Preoperative Urine Culture Results
Non-disclosure of preoperative urine culture results
Other: Blinding to Preoperative Urine Culture Results
In this arm, the results of the preoperative urine culture will be made available to the treating urologist.
In this arm, the results of the preoperative urine culture will not be made available to the treating urologist.
Urinary tract infection (UTI)
UTI was defined according to the American Urological Association (AUA) antimicrobial prophylaxis guidelines (43), supplemented by the European Association of Urology (EAU) UTI diagnostic criteria (10). Patients were classified as having a UTI if they met any of 4 scenarios: (1) ≥1 urinary symptom or fever, positive urine culture (\>10⁵ CFU), and surgeon-confirmed post-endoscopic UTI; (2) ≥2 urinary symptoms or fever plus supportive laboratory findings or clinical diagnosis; (3) postoperative fever with imaging suggestive of pyelonephritis after TURP, or catheter-associated UTI with ≥10³ CFU/mL within the specified catheterization period; or (4) ≥2 persistent urinary symptoms for \>1 week after catheter removal, without fever or improvement, plus positive urine culture (\>10⁵ CFU) and surgeon-confirmed post-endoscopic UTI.
Time frame: 30 days or 1 month
Urinary sepsis
Patients will be diagnosed with rrinary sepsis if they meet the criteria: * The patient has a recognized pathogen cultured from one or more blood culture specimens; AND * The organism isolated from the blood is not associated with an infection at another site; AND * The patient presents with at least one of the following signs or symptoms: fever (\>38 °C), chills, hypotension or septic shock, or organ dysfunction; AND * The signs and symptoms, as well as the positive laboratory findings, are not attributable to an infection at another site. In clinical practice, organ dysfunction may be indicated by a Quick Sequential Organ Failure Assessment (qSOFA) score of ≥2. The qSOFA criteria are a respiratory rate of ≥22 breaths/min, altered mental status, or systolic blood pressure of ≤100mmHg. Septic shock will be defined as the requirement for vasopressors to maintain a mean arterial pressure of ≥65 mmHg, together with a serum lactate level of \>2 mmol/L(\>18 mg/dL), in the absence of hypovolemia
Time frame: 30 days or 1 month
Acute orchiepididymitis
Acute orchiepididymitis will be defined as the presence of scrotal pain, swelling, increased temperature, and inflammatory changes, accompanied by testicular and/or epididymal tenderness and enlargement on palpation; or inflammatory changes involving the testis and/or epididymis, with increased blood flow on color Doppler ultrasonography, with or without intratesticular collections on ultrasound examination. These findings may occur regardless of whether the urine culture is positive.
Time frame: 30 days or 1 month
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Nov 2026; primary completion for Nov 2029, 36 months later.
Of 153 non-industry interventional studies with no phase under Prostatic Hyperplasia, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 48. This study's planned 36 months is above that.
Counting every sponsor, half of 205 studies reached it within 26 months; a quarter within 15 and three quarters within 48.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidad de Antioquia